Toshiba introduces Spot Fluoroscopy for Infinix-i systems

Giving clinicians a more complete picture while improving safety during interventional procedures, Toshiba America Medical Systems, Inc. introduces Spot Fluoroscopy for its Infinix™-i systems. Enabling quicker diagnoses and lower dose, clinicians can observe a target region of anatomy using Spot Fluoro's live fluoroscopy while viewing the Last Image Hold (LIH) surrounding area.

"Spot Fluoroscopy is like having an adjustable spot light over the reference LIH image, helping to reduce dose exposure and allowing the clinician to view the critical region of interest and the surrounding area at the same time," said Stephen Bumb, director, X-ray Vascular Business Unit, Toshiba. "This unique type of unconventional collimation streamlines interventional procedures and reduces radiation exposure to both clinicians and patients, making exams safer for everyone involved."

Spot Fluoroscopy is being showcased at this year's Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 - 30, 2012 (Booth #3438, South Hall).

Source:

Toshiba America Medical Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.